Audentes Therapeutics is now Astellas Gene Therapies. Read our Press Release and visit www.astellas.com to learn more.

Astellas Pharma Inc.
  • Top MenuTeam
  • Top MenuOur Approach
  • Top MenuInnovative Therapies
    • X-Linked Myotubular Myopathy
    • Pompe Disease
    • Myotonic Dystrophy Type 1
  • Top MenuCareers
  • Top MenuNews
  • Top MenuContact
  • Top MenuPatients + Families
  1. Home
  2. News

News

Feb 22, 2023
Astellas Announces Update on Preliminary Safety and Efficacy Data from FORTIS Study of Investigational AT845 in Adults with Late-Onset Pompe Disease
Read More
Jan 20, 2023
Astellas Announces Hold Lifted by FDA on FORTIS Clinical Trial of AT845 Investigational Treatment for Adult Patients with Late-Onset Pompe Disease
Read More
Jan 09, 2023
Selecta Biosciences and Astellas Announce Exclusive Licensing and Development Agreement for Xork IgG Protease
Read More
Oct 25, 2022
Astellas and Taysha Gene Therapies Announce Strategic Investment to Support Development of Taysha’s AAV-based Gene Therapy Programs
Read More
Jul 26, 2022
Astellas Unveils Plans to Open New Biotech Campus in South San Francisco
Read More
Jun 27, 2022
Astellas Announces FDA Update on the FORTIS Clinical Trial of AT845 in Adults with Late-Onset Pompe Disease
Read More
Jun 08, 2022
Astellas Celebrates the Opening of Its New Large-Scale Gene Therapy Manufacturing Facility in North Carolina
Read More
Apr 22, 2022
Notice Regarding Impairment Loss for Products under Development
Read More
Feb 07, 2022
Astellas Announces Positive Safety Data from the FORTIS Study of AT845 in Adults with Late-Onset Pompe Disease
Read More

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page Next ›
  • Last page Last »

Footer Menu 1

  • TEAM
  • OUR APPROACH

Footer Menu 2

  • INNOVATIVE THERAPIES
    • X-Linked Myotubular Myopathy
    • Pompe Disease
    • Myotonic Dystrophy Type 1

Footer Menu 3

  • CAREERS
  • NEWS
  • CONTACT
  • PATIENTS + FAMILIES
  • US PRIVACY POLICY
  • EU PRIVACY POLICY

225 Gateway Blvd., South
San Francisco, CA 94080
Phone: (415) 818-1005
Email: [email protected]

 

© Copyright 2023 Audentes Therapeutics. Terms and Conditions | Privacy Statement

Update cookie preferences

  • facebook icon
  • linkedin icon
  • twitter icon
back to top